191 filings
PRE 14A
IKT
Inhibikase Therapeutics Inc
Preliminary proxy
10 Jun 24
4:20pm
8-K
IKT
Inhibikase Therapeutics Inc
10 Jun 24
Submission of Matters to a Vote of Security Holders
4:05pm
D
IKT
Inhibikase Therapeutics Inc
4 Jun 24
$8.00 mm in equity / options / securities to be acquired, 1 investor
4:11pm
424B5
IKT
Inhibikase Therapeutics Inc
22 May 24
Prospectus supplement for primary offering
8:55am
8-K
IKT
Inhibikase Therapeutics Inc
20 May 24
Inhibikase Therapeutics Announces Pricing of Registered Direct Offering and Warrant
8:55am
424B5
IKT
Inhibikase Therapeutics Inc
20 May 24
Prospectus supplement for primary offering
7:09am
10-Q
2024 Q1
IKT
Inhibikase Therapeutics Inc
Quarterly report
15 May 24
5:04pm
RW
IKT
Inhibikase Therapeutics Inc
15 May 24
Registration withdrawal request
7:56am
S-1/A
IKT
Inhibikase Therapeutics Inc
IPO registration (amended)
9 May 24
2:41pm
S-1/A
IKT
Inhibikase Therapeutics Inc
IPO registration (amended)
8 May 24
8:44pm
8-K
IKT
Inhibikase Therapeutics Inc
30 Apr 24
Regulation FD Disclosure
8:17am
S-1/A
IKT
Inhibikase Therapeutics Inc
IPO registration (amended)
29 Apr 24
4:33pm
DEFA14A
IKT
Inhibikase Therapeutics Inc
26 Apr 24
Additional proxy soliciting materials
4:30pm
ARS
2023 FY
IKT
Inhibikase Therapeutics Inc
26 Apr 24
Annual report to shareholders
4:20pm
DEF 14A
IKT
Inhibikase Therapeutics Inc
Definitive proxy
26 Apr 24
4:15pm
S-1/A
IKT
Inhibikase Therapeutics Inc
IPO registration (amended)
25 Apr 24
4:29pm
S-1
IKT
Inhibikase Therapeutics Inc
IPO registration
19 Apr 24
5:14pm
8-K
IKT
Inhibikase Therapeutics Inc
18 Apr 24
Inhibikase Therapeutics Issues Letter to Shareholders and Provides Update on Development Programs
9:46pm
PRE 14A
IKT
Inhibikase Therapeutics Inc
Preliminary proxy
15 Apr 24
4:09pm
4
Milton H. Werner
3 Apr 24
Inhibikase Therapeutics / Milton H. Werner ownership change
4:47pm